Gerald Farrokh Daneshvar

Gerald Farrokh Daneshvar, M.D. has held various positions in the medical field since 2007. In 2007, they were a Research Assistant at The National Institutes of Health. From 2011 to 2013, they were a Medical Reviewer at MedXM, and a Clinical Consultant at Andrologix Health and Wellness. From 2014 to 2017, they were a Quality Assurance Physician at Octapharma Plasma, Inc., and a Plasma Center Director at CSL Behring. Since 2021, they have been a Business Development Executive at American Gene Technologies International Inc., and a COVID Laboratory Physician. Since 2023, they have been an Adjunct Faculty at George Mason University - School of Business, teaching MGMT 453 for the School of Business.

Gerald Farrokh Daneshvar, M.D. began their education at the University of Michigan, where they earned a B.S. in Biology in 1999. Gerald Farrokh then attended Case Western Reserve University School of Medicine, where they received their M.D. in 2003. Following this, they completed post-graduate training at the University of Michigan from 2004-2005, followed by post-graduate training at the University of Maryland, Baltimore Graduate School from 2005-2007. Finally, they completed post-graduate training at Penn State University from 2008-2011.